Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

(2020) Weilong Shang et al.   npj Vaccines

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

(2020) Milagritos D Tapia et al.   LANCET INFECTIOUS DISEASES

Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS–STING signalling

(2019) James B. Eaglesham et al.   NATURE

Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox

(2019) Phillip R. Pittman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe Acute Respiratory Syndrome

(2019) David S.C. Hui et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism

(2017) Youdong Pan et al.   NATURE

Lessons learned from human HIV vaccine trials

(2017) Justin Pollara et al.   Current Opinion in HIV and AIDS

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines

(2016) Clement A. Meseda et al.   PLoS One

Polio vaccination: past, present and future

(2015) Ananda S Bandyopadhyay et al.   Future Microbiology

The emerging role of resident memory T cells in protective immunity and inflammatory disease

(2015) Chang Ook Park et al.   NATURE MEDICINE

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

(2014) Annett Hessel et al.   PLoS One

Contemporary Vaccine Challenges: Improving Global Health One Shot at a Time

(2014) W. A. Orenstein et al.   Science Translational Medicine

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

(2014) Arwen Altenburg et al.   Viruses-Basel

Toward a Universal Influenza Virus Vaccine: Prospects and Challenges

(2013) Natalie Pica et al.   Annual Review of Medicine

Recombinant MVA vaccines: dispelling the myths

(2013) Matthew G. Cottingham et al.   VACCINE

Modified Vaccinia Virus Ankara-Based Vaccine Vectors Induce Apoptosis in Dendritic Cells Draining from the Skin via both the Extrinsic and Intrinsic Caspase Pathways, Preventing Efficient Antigen Presentation

(2012) E. Guzman et al.   JOURNAL OF VIROLOGY

What was the primary mode of smallpox transmission? Implications for biodefense

(2012) Donald K. Milton   Frontiers in Cellular and Infection Microbiology

Understanding Smallpox Vaccination

(2011) M. Bray   JOURNAL OF INFECTIOUS DISEASES

Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells

(2011) Shari N. Gordon et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration

(2010) Marissa B. Wilck et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax

(2010) Michael S. Seaman et al.   JOURNAL OF INFECTIOUS DISEASES

Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell–mediated immunity

(2010) Luzheng Liu et al.   NATURE MEDICINE